A Study of CDX-0159 in Patients With Chronic Inducible Urticaria
Public ClinicalTrials.gov record NCT05405660. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
: A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Dose-ranging Study to Assess the Efficacy and Safety of CDX-0159 in Patients With Chronic Inducible Urticaria
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the clinical effect, the pharmacodynamics, the safety, and the pharmacokinetics of barzolvolimab (CDX-0159) in patients with Chronic Inducible Urticaria who remain symptomatic despite the use of H1-antihistamines.
Study identification
- NCT ID
- NCT05405660
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 196 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 28, 2022 (Actual)
- Primary completion
- Jun 12, 2024 (Actual)
- Completion
- Sep 12, 2025 (Actual)
- Last update posted
- Nov 6, 2025
2022 – 2025
United States locations
- U.S. sites
- 16
- U.S. states
- 14
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Research Center of Alabama | Birmingham | Alabama | 35249 | — |
| Allervie Clinical Research | Montgomery | Alabama | 36106 | — |
| One of a Kind Clinical Research Center, LLC | Paradise Valley | Arizona | 85253 | — |
| Little Rock Allergy & Asthma CRC | Little Rock | Arkansas | 72205 | — |
| Kern Research, Inc | Bakersfield | California | 93301 | — |
| Allergy & Asthma Consultants | Redwood City | California | 94063 | — |
| IMMUNOe Research Centers | Centennial | Colorado | 80112 | — |
| Sarasota Clinical Research | Sarasota | Florida | 34239 | — |
| Treasure Valley Medical Research | Boise | Idaho | 83706 | — |
| Dawes Fretzin Dermatology Group, LLC | Indianapolis | Indiana | 46250 | — |
| Allergy & Asthma Specialists, PSC | Owensboro | Kentucky | 42301 | — |
| Institute for Asthma and Allergy, PC/Department of Clinical Research | Chevy Chase | Maryland | 20815 | — |
| Respiratory Medicine Research Institute of Michigan, PLC | Ypsilanti | Michigan | 48197 | — |
| University of Cincinnati | Cincinnati | Ohio | 45267 | — |
| Allergy Partners of Kerrville | Kerrville | Texas | 78028 | — |
| Allergy Associates of Utah | Murray | Utah | 84107 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 60 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05405660, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 6, 2025 · Synced Nov 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05405660 live on ClinicalTrials.gov.